Mirimus
VerifiedProducer of custom genetically-engineered mouse models with reverse gene silencing capabilities.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$8—12m (Dealroom.co estimates Mar 2011.)
New York City New York (HQ)
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | $0.0 | round |
investor | $0.0 | round | |
N/A | $0.0 | round | |
investor | $0.0 | round | |
investor | $0.0 | round | |
investor | $0.0 | round | |
N/A | $400k | Grant | |
Total Funding | 000k |
Related Content
Recent News about Mirimus
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.